Analysis: A look at why Prozac is only antidepressant OK'd for youths

09/21/2004 | NYTimes.com

In the wake of an FDA advisory committee recommendation calling for warnings on antidepressants meant for children, Eli Lilly's Prozac remains the only FDA-approved treatment for pediatric depression, even though experts say it is functionally no different than its competitors. It may be different in chemical terms, but it works on the same principle, the experts say, and it has not been proven safer or more effective than competing antidepressants. A medical adviser to Eli Lilly said "the drug is safe and effective in children."

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC